Arlington, VA — The American Consumer Institute joined five other organizations in warning against the consequences of imposing tariffs on generic and biosimilar medications. Such tariffs would raise drug prices for Americans and risk worsening existing supply constraints, limiting access to critically needed treatments.
Read the full letter below.
Check out ACI’s work on this issue here.